Laurent Drouot

2.2k total citations
28 papers, 990 citations indexed

About

Laurent Drouot is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Laurent Drouot has authored 28 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Laurent Drouot's work include Inflammatory Myopathies and Dermatomyositis (15 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Muscle Physiology and Disorders (5 papers). Laurent Drouot is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (15 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Muscle Physiology and Disorders (5 papers). Laurent Drouot collaborates with scholars based in France, United States and Belgium. Laurent Drouot's co-authors include Olivier Boyer, Olivier Benvéniste, Yves Allenbach, F. Jouen, I. Marie, Lucile Musset, Louiza Arouche-Delaperche, Bertrand Knebelmann, Corinne Antignac and S. Herson and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Laurent Drouot

28 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent Drouot France 17 612 337 254 229 150 28 990
Corinna Preuße Germany 15 693 1.1× 354 1.1× 225 0.9× 232 1.0× 152 1.0× 56 967
Akinori Uruha Japan 17 853 1.4× 330 1.0× 381 1.5× 192 0.8× 301 2.0× 51 1.1k
Alison M. Emslie‐Smith United States 13 841 1.4× 572 1.7× 359 1.4× 200 0.9× 193 1.3× 16 1.3k
Ronan J. Walsh United States 10 422 0.7× 287 0.9× 271 1.1× 181 0.8× 64 0.4× 13 721
Yue‐Bei Luo China 18 275 0.4× 403 1.2× 126 0.5× 191 0.8× 162 1.1× 52 906
Edward P. Trieu United States 10 737 1.2× 262 0.8× 522 2.1× 263 1.1× 65 0.4× 13 1.0k
Sarah Tansley United Kingdom 18 1.4k 2.3× 332 1.0× 887 3.5× 406 1.8× 136 0.9× 50 1.6k
Yu Oyama United States 19 195 0.3× 278 0.8× 161 0.6× 398 1.7× 109 0.7× 44 1.5k
Yuko Ota Japan 17 977 1.6× 242 0.7× 801 3.2× 325 1.4× 69 0.5× 24 1.4k
T Sano Japan 22 172 0.3× 224 0.7× 216 0.9× 106 0.5× 150 1.0× 39 1.3k

Countries citing papers authored by Laurent Drouot

Since Specialization
Citations

This map shows the geographic impact of Laurent Drouot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Drouot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Drouot more than expected).

Fields of papers citing papers by Laurent Drouot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Drouot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Drouot. The network helps show where Laurent Drouot may publish in the future.

Co-authorship network of co-authors of Laurent Drouot

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Drouot. A scholar is included among the top collaborators of Laurent Drouot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Drouot. Laurent Drouot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malleter, Marine, et al.. (2024). Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies. 13(1). 12–12. 4 indexed citations
2.
Abad, Catalina, Iago Pinal‐Fernandez, C. Le Guillou, et al.. (2024). IFNγ causes mitochondrial dysfunction and oxidative stress in myositis. Nature Communications. 15(1). 5403–5403. 23 indexed citations
3.
Drouot, Laurent, J. Martinet, Chantal Bécourt, et al.. (2023). Icos gene disruption in non‐obese diabetic mice elicits myositis associated with anti‐troponin T3 autoantibodies. Neuropathology and Applied Neurobiology. 49(1). e12889–e12889. 3 indexed citations
4.
Gandolfi, S., et al.. (2023). Stromal vascular fraction in the treatment of myositis. Cell Death Discovery. 9(1). 346–346. 8 indexed citations
5.
Vadysirisack, Douangsone D., Yalan Tang, Laetitia Jean, et al.. (2022). Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model. Biomedicines. 10(8). 2036–2036. 19 indexed citations
6.
Drouot, Laurent, Sébastien Hantz, F. Jouen, et al.. (2020). Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay. Frontiers in Microbiology. 11. 603931–603931. 3 indexed citations
7.
Allenbach, Yves, Louiza Arouche-Delaperche, Christophe Arnoult, et al.. (2018). In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy. Annals of the Rheumatic Diseases. 78(1). 131–139. 117 indexed citations
8.
Benhamou, Y., S. Miranda, G. Armengol, et al.. (2015). Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress. Vascular Pharmacology. 71. 93–101. 20 indexed citations
9.
Hardet, Romain, Benjamin Chevalier, Gaëtan Riou, et al.. (2015). Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector. Molecular Therapy. 24(1). 87–95. 16 indexed citations
10.
Allenbach, Yves, Marguerite Guiguet, Aude Rigolet, et al.. (2015). Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial. PLoS ONE. 10(11). e0133702–e0133702. 92 indexed citations
12.
Drouot, Laurent, Claire Dauly, Sahil Adriouch, et al.. (2013). Overexpression of MHC Class I in Muscle of Lymphocyte-Deficient Mice Causes a Severe Myopathy with Induction of the Unfolded Protein Response. American Journal Of Pathology. 183(3). 893–904. 38 indexed citations
14.
Benvéniste, Olivier, Laurent Drouot, F. Jouen, et al.. (2011). Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis & Rheumatism. 63(7). 1961–1971. 156 indexed citations
15.
Auquit-Auckbur, I., Frédérique Caillot, Christophe Arnoult, et al.. (2011). Role of Toll-like receptor 4 in the inflammation reaction surrounding silicone prosthesis. Acta Biomaterialia. 7(5). 2047–2052. 14 indexed citations
16.
Drouot, Laurent, et al.. (2005). Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW × BXSB)F1mice and human systemic lupus erythematosus. Arthritis Research & Therapy. 7(6). R1394–403. 10 indexed citations
17.
19.
Knebelmann, Bertrand, Lionel Forestier, Laurent Drouot, et al.. (1995). Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Human Molecular Genetics. 4(4). 675–679. 89 indexed citations
20.
Antignac, Corinne, Bertrand Knebelmann, Laurent Drouot, et al.. (1994). Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.. Journal of Clinical Investigation. 93(3). 1195–1207. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026